Loading clinical trials...

Avelumab in First-line NSCLC (JAVELIN Lung 100) | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT02576574

Avelumab in First-line NSCLC (JAVELIN Lung 100)

The purpose of this study was to demonstrate superiority with regard to Overall Survival (OS) or Progression Free Survival (PFS) of avelumab versus platinum-based doublet, based on an Independent Revi...

Lead sponsor: EMD Serono Research & Development Institute, Inc.•21 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment1,214

Start dateOct 2015

Last updatedJan 31, 2025

Condition

First Line Non-Small Cell Lung Cancer

Locations shown

Clearview Cancer Institute

Huntsville, Alabama

Arizona Center for Cancer Care

Surprise, Arizona

Sharp Memorial Hospital

San Diego, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 31, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions